Diabetes mellitus association with coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis
糖尿病与冠状病毒病2019(COVID-19)的严重程度和死亡率的关联:汇总分析
Gaurav Aggarwal
Department of Medicine, Jersey City Medical Center, Jersey City, New Jersey, USA
Search for more papers by this authorGiuseppe Lippi
Section of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy
Search for more papers by this authorCarl J. Lavie
John Ochsner Heart and Vascular Institute, Ochsner Clinical School - The University of Queensland School of Medicine, New Orleans, Louisiana, USA
Search for more papers by this authorCorresponding Author
Brandon Michael Henry
Cardiac Intensive Care Unit, The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
Correspondence
Brandon Michael Henry, Cardiac Intensive Care Unit, The Heart Institute, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229.
Email: [email protected]
Search for more papers by this authorFabian Sanchis-Gomar
Department of Physiology, Faculty of Medicine, University of Valencia and INCLIVA Biomedical Research Institute, Valencia, Spain
Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, USA
Search for more papers by this authorGaurav Aggarwal
Department of Medicine, Jersey City Medical Center, Jersey City, New Jersey, USA
Search for more papers by this authorGiuseppe Lippi
Section of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy
Search for more papers by this authorCarl J. Lavie
John Ochsner Heart and Vascular Institute, Ochsner Clinical School - The University of Queensland School of Medicine, New Orleans, Louisiana, USA
Search for more papers by this authorCorresponding Author
Brandon Michael Henry
Cardiac Intensive Care Unit, The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
Correspondence
Brandon Michael Henry, Cardiac Intensive Care Unit, The Heart Institute, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH, 45229.
Email: [email protected]
Search for more papers by this authorFabian Sanchis-Gomar
Department of Physiology, Faculty of Medicine, University of Valencia and INCLIVA Biomedical Research Institute, Valencia, Spain
Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California, USA
Search for more papers by this authorFunding information: Subprograma Atracció de Talent - Contractes Postdoctorals de la Universitat de València
Graphical Abstract
Highlights
- There are ~ 2-fold increased odds of severe coronavirus disease 2019 (COVID-19) and a ~ 2-fold increased risk of odds of mortality in patients with history of diabetes mellitus compared to those without diabetes mellitus.
- Patients with a history of diabetes mellitus should be closely monitored if they get infected with COVID-19.
Results of meta-analysis showing association of diabetes mellitus with severity (Panel A) of disease and mortality (Panel B) in coronavirus disease 2019 (COVID-19) patients
Supporting Information
| Filename | Description |
|---|---|
| jdb13091-sup-0001-FigureS1.jpgJPEG image, 156.7 KB | Figure S1 Results of meta-regression showing no impact of age on association of diabetes mellitus with severity of disease (Panel A) or mortality (Panel B) in coronavirus disease 2019 (COVID-19) patients. |
| jdb13091-sup-0002-FigureS2.jpgJPEG image, 572.9 KB | Figure S2 Results of meta-regression showing no impact of gender on association of diabetes mellitus with severity of disease (Panel A) or mortality (Panel B) in coronavirus disease 2019 (COVID-19) patients |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- 1Lippi G, Sanchis-Gomar F, Henry BM. Coronavirus disease 2019 (COVID-19): the portrait of a perfect storm. Ann Transl Med. 2020; 8: 497. https://doi.org/10.21037/atm.2020.03.157.
- 2Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch Acad Emerg Med. 2020; 8(1): e35.
- 3Deng Y, Liu W, Liu K, et al. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study. Chin Med J (Engl). 2020; 133: 1261-1267.
- 4Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382: 1708-1720.
- 5Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223): 497-506.
- 6Liu W, Tao ZW, Lei W, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl). 2020; 133(9): 1032-1038.
- 7Liu Y, Yang Y, Zhang C, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020; 63(3): 364-374.
- 8Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020; 71(15): 762-768.
- 9Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020; 46(5): 846-848.
- 10Wan S, Xiang Y, Fang W, et al. Clinical features and treatment of COVID-19 patients in Northeast Chongqing. J Med Virol. 2020; 92: 797-806.
- 11Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323: 1061.
- 12Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 2020; 71(15): 769-777.
- 13Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020; 180: 934.
- 14Tianxin X, Jiaming L, Fei X, et al. Analysis of clinical characteristics of 49 patients with new type of coronavirus pneumonia in Jiangxi region. Chin J Resp Crit Car. 2020; 19: 154-160.
- 15Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020; 8: 475-481.
- 16Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020; 75: 1730-1741.
- 17Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229): 1054-1062.
- 18Chen C, Chen C, Jiangtao Y, Ning Z, Jianping Z, Daowen W. Analysis of myocardial injury and cardiovascular diseases in critical patients with new coronavirus pneumonia. Chin J Cardiovasc Dis. 2020.
- 19Rodriguez BL, Abbott RD, Fujimoto W, et al. The American Diabetes Association and World Health Organization classifications for diabetes. Their impact on diabetes prevalence and total and cardiovascular disease mortality in elderly Japanese-American men. Diabetes Care. 2002; 25(6): 951-955.
- 20Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003; 289(21): 2801-2809.
- 21Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020; 395(10229): 1033-1034.
Citing Literature
